Please assess the completion status of the following clinical trial:

Trial Title: Follicular Steroid Genesis in Controlled Ovarian Stimulation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Good physical and psychological condition~* Normal menstrual cycle (25-35 days)~* Normal ovarian reserve defined by serum ANH010-30 pMol/L~* All other criteria to fulfill by oocyte donors~Exclusion Criteria:~* Kidney failure~* Ovarian Polyquistic syndrome~* Any systemic or metabolic disfunction that counter indicates the use of gonadotrophins~* Any other reason that involves exclusion of the oocyte donation program

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- rFSH (Type: ACTIVE_COMPARATOR): Controlled ovarian hyperstimulation with GnRH antagonists and rFSH in women with normal ovarian function.
- HP-HMG (Type: ACTIVE_COMPARATOR): Controlled ovarian hyperstimulation with GnRH antagonists and HP-HMG with normal ovarian function.

Based on this trial design, predict the completion outcome and termination type (if applicable).